MARKET

NAII

NAII

Naturl Alt Intl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.14
-0.34
-3.24%
After Hours: 10.14 0 0.00% 16:00 05/16 EDT
OPEN
10.47
PREV CLOSE
10.48
HIGH
10.55
LOW
10.14
VOLUME
3.80K
TURNOVER
0
52 WEEK HIGH
19.93
52 WEEK LOW
8.42
MARKET CAP
62.07M
P/E (TTM)
6.42
1D
5D
1M
3M
1Y
5Y
Natural Alternatives GAAP EPS of $0.41, revenue of $42.4M
Natural Alternatives press release (NASDAQ:NAII): Q3 GAAP EPS of $0.41. Revenue of $42.4M (-8.4% Y/Y).
Seekingalpha · 3d ago
BRIEF-Natural Alternatives International Posts Q3 EPS $0.41
reuters.com · 3d ago
Natural Alternatives Q3 EPS $0.41 Up From $0.30 YoY, Sales $42.37M Down From $46.32M YoY
Natural Alternatives (NASDAQ:NAII) reported quarterly earnings of $0.41 per share. This is a 36.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported $42.37 million in
Benzinga · 3d ago
-- Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q3 Revenue $42.4M
MT Newswires · 3d ago
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 211 companies set new 52-week lows.
Benzinga · 05/03 16:20
Stocks That Hit 52-Week Lows On Monday
    On Monday, 466 companies hit new 52-week lows.
Benzinga · 04/18 15:40
Here's What's Concerning About Natural Alternatives International's (NASDAQ:NAII) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Simply Wall St. · 04/18 10:22
5 Value Stocks In The Consumer Defensive Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most ...
Benzinga · 04/08 14:40
More
No Data
Learn about the latest financial forecast of NAII. Analyze the recent business situations of Naturl Alt Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.21%
Pharmaceuticals & Medical Research
+1.02%
Key Executives
Chairman/Chief Executive Officer/Director
Mark Ledoux
President/Chief Operating Officer/Secretary
Kenneth Wolf
Chief Financial Officer/IR Contact Officer
Michael Fortin
Independent Director
Alan Dunn
Independent Director
Laura Matherly
Independent Director
Guru Ramanathan
No Data
No Data
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates in two segments: private-label contract manufacturing, and patent and trademark licensing. The private-label contract manufacturing segment primarily relates to the provision of private-label contract manufacturing services to companies that market and distribute nutritional supplements and other health care products. The patent and trademark licensing segment primarily include direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnoSyn and SR CarnoSyn trade names. Its products and services to customers include scientific research, clinical studies, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, and international product registration assistance.

Webull offers kinds of Natural Alternatives International, Inc. stock information, including NASDAQ:NAII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NAII stock methods without spending real money on the virtual paper trading platform.